As of 2026-09-09, the Relative Valuation of Bioventus Inc (BVS) is 13.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.83 USD, the upside of Bioventus Inc based on Relative Valuation is 0.0%.
The range of the Relative Valuation is 12.40 - 15.29 USD.
| Range | Selected | |
| Trailing P/E multiples | 37.9x - 46.7x | 42.3x |
| Forward P/E multiples | 33.3x - 36.8x | 36.2x |
| Fair Price | 12.40 - 15.29 | 13.83 |
| Upside | -10.4% - 10.6% | 0.0% |
| Date | P/E |
| 2026-09-04 | 43.01 |
| 2026-09-03 | 43.90 |
| 2026-09-02 | 43.93 |
| 2026-09-01 | 41.79 |
| 2026-08-31 | 41.73 |
| 2026-08-28 | 42.31 |
| 2026-08-27 | 42.16 |
| 2026-08-26 | 42.71 |
| 2026-08-25 | 43.04 |
| 2026-08-24 | 42.86 |
| 2026-08-21 | 43.96 |
| 2026-08-20 | 43.81 |
| 2026-08-19 | 44.88 |
| 2026-08-18 | 43.72 |
| 2026-08-17 | 42.43 |
| 2026-08-14 | 43.59 |
| 2026-08-13 | 42.46 |
| 2026-08-12 | 42.54 |
| 2026-08-11 | 42.34 |
| 2026-08-10 | 42.68 |
| 2026-08-07 | 43.18 |
| 2026-08-06 | 42.74 |
| 2026-08-05 | 46.65 |
| 2026-08-04 | 41.02 |
| 2026-08-03 | 41.18 |
| 2026-07-31 | 40.26 |
| 2026-07-30 | 40.29 |
| 2026-07-29 | 40.11 |
| 2026-07-28 | 40.38 |
| 2026-07-27 | 38.06 |
| 2026-07-24 | 36.07 |
| 2026-07-23 | 35.09 |
| 2026-07-22 | 35.55 |
| 2026-07-21 | 36.32 |
| 2026-07-20 | 35.40 |
| 2026-07-17 | 36.87 |
| 2026-07-16 | 38.00 |
| 2026-07-15 | 36.59 |
| 2026-07-14 | 35.34 |
| 2026-07-13 | 36.90 |
| 2026-07-10 | 36.32 |
| 2026-07-09 | 37.36 |
| 2026-07-08 | 37.02 |
| 2026-07-07 | 35.12 |
| 2026-07-06 | 36.01 |
| 2026-07-02 | 32.04 |
| 2026-07-01 | 30.11 |
| 2026-06-30 | 28.86 |
| 2026-06-29 | 29.90 |
| 2026-06-26 | 29.90 |